Search Results - "Xie, Yingda L."

Refine Results
  1. 1

    Alternative Methods for Therapeutic Drug Monitoring and Dose Adjustment of Tuberculosis Treatment in Clinical Settings: A Systematic Review by Rao, Prakruti S., Modi, Nisha, Nguyen, Nam-Tien Tran, Vu, Dinh Hoa, Xie, Yingda L., Gandhi, Monica, Gerona, Roy, Metcalfe, John, Heysell, Scott K., Alffenaar, Jan-Willem C.

    Published in Clinical pharmacokinetics (01-03-2023)
    “…Background and Objective Quantifying exposure to drugs for personalized dose adjustment is of critical importance in patients with tuberculosis who may be at…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    RT-PCR negative COVID-19 by Parmar, Heta, Montovano, Margaret, Banada, Padmapriya, Pentakota, Sri Ram, Shiau, Stephanie, Ma, Zhongjie, Saibire, Kaheerman, Chopoorian, Abby, O'Shaughnessy, Michael, Hirsch, Mitchell, Jain, Priyanshi, Demirdjian, Gaiane, Karagueuzian, Magali, Robin, Thomas, Salvati, Michael, Patel, Bhavana, Alland, David, Xie, Yingda L

    Published in BMC infectious diseases (13-02-2022)
    “…COVID-19 is a multi-system infection with emerging evidence-based antiviral and anti-inflammatory therapies to improve disease prognosis. However, a subset of…”
    Get full text
    Journal Article
  5. 5

    Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell disease by Luethy, Paul M, Murphy, Sean C, Seilie, Annette M, Xie, Yingda L, Lau, Chuen-Yen, Tisdale, John F, Hsieh, Matthew M, Reinhardt, Jessica L, Lau, Anna F, Fahle, Gary A

    Published in Malaria journal (10-01-2018)
    “…Autosplenectomy, as a result of sickle cell disease, is an important risk factor for severe malaria. While molecular methods are helpful in providing rapid and…”
    Get full text
    Journal Article
  6. 6

    New approach to rifampicin stability and first-line anti-tubercular drug pharmacokinetics by UPLC-MS/MS by Karaźniewicz-Łada, Marta, Kosicka-Noworzyń, Katarzyna, Rao, Prakruti, Modi, Nisha, Xie, Yingda L, Heysell, Scott K, Kagan, Leonid

    “…Successful tuberculosis (TB) therapy requires achieving sufficient exposure to multiple drugs. Limited stability of several first-line anti-TB drugs might…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing by Banada, Padmapriya, Elson, David, Daivaa, Naranjargal, Park, Claire, Desind, Samuel, Montalvan, Ibsen, Kwiatkowski, Robert, Chakravorty, Soumitesh, Alland, David, Xie, Yingda L

    Published in Journal of medical microbiology (01-09-2021)
    “…Non-invasive sample collection and viral sterilizing buffers have independently enabled workflows for more widespread COVID-19 testing by reverse-transcriptase…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Transmission of Mycobacterium tuberculosis From Patients Who Are Nucleic Acid Amplification Test Negative by Xie, Yingda L, Cronin, Wendy A, Proschan, Michael, Oatis, Richard, Cohn, Silvia, Curry, Scott R, Golub, Jonathan E, Barry, Clifton E, Dorman, Susan E

    Published in Clinical infectious diseases (13-11-2018)
    “…We assessed the transmission risk of pulmonary tuberculosis patients whose sputum nucleic acid amplification tests (NAAT) were negative. We estimated that, at…”
    Get full text
    Journal Article
  15. 15

    Severe Paradoxical Reaction During Treatment of Disseminated Tuberculosis in a Patient With Neutralizing Anti-IFNγ Autoantibodies by Xie, Yingda L., Rosen, Lindsey B., Sereti, Irini, Barber, Daniel L., Chen, Ray Y., Hsu, Denise C., Qasba, S. Sonia, Zerbe, Christa S., Holland, Steven M., Browne, Sarah K.

    Published in Clinical infectious diseases (15-03-2016)
    “…Interferon-gamma (IFNγ) neutralizing autoantibodies are associated with disseminated nontuberculous mycobacterial infections. We report a previously healthy…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis by Abadie, Miriam E, Strich, Jeffrey R, Kim, Tiffany, Xie, Yingda L, Fennelly, Kevin P, Olivier, Kenneth N, Waldman, Meryl, Arora, Kriti, Holland, Steven M, Chen, Ray Y

    Published in The European respiratory journal (01-12-2017)
    “…We read with interest the papers by Tiberi et al. [1, 2] describing the effectiveness of meropenem/clavulanate in treating multidrug-resistant (MDR) and…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Neurotuberculosis: Control of Steroid-Refractory Paradoxical Inflammatory Reaction With Ruxolitinib by Xie, Yingda L, Ita-Nagy, Fanny, Chen, Ray Y, Manion, Maura M, Sereti, Irini, Pei, Luxin, Holland, Steven M

    Published in Open forum infectious diseases (01-10-2019)
    “…Abstract Paradoxical inflammatory reactions associated with treatment of neurotuberculosis can lead to severe morbidity and mortality and may not be controlled…”
    Get full text
    Journal Article